Drug Designing: Open Access
Open Access

Global Summit on Clinical Trials of Cancer Research

Qiao Li^{* *}Correspondence: Qiao Li, Animal Studies and Clinical Trials in Cancer Immunotherapy, University of Michigan, United States, Email:

Author info »

Worldwide cancer affects more than 10 million people each year and the incidence of cancer is expected to increase by 2.4% annually to reach 14 million per year by 2020. Cancer is the second most common death in the industrialized world.

Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.

There is a consistently expanding financial cost trouble being applied on national governments and an offer to diminish the monetary cost trouble is requesting inventive and propelled wound consideration items in the worldwide market.

Descriptive summary characteristics of the 105 patients who consented to research autopsies over the first 1.5 years of the programme are outlined. Patient age ranged from 24 to 86 years (median, 65 years), and gender distribution was 57 males and 48 females. Cancer types (were 21 gastrointestinal cancers (oesophageal, gastric, colorectal, pancreatic, liver and biliary), 19 respiratory tract cancers (non-small cell carcinoma, small cell carcinoma and others), 18 genitourinary tract-related cancers, 17 melanomas, 9 gynaecological cancers, 8 breast cancers, 5 haematological malignancies (multiple myeloma, CLL with blastoid transformation and biphenotypic acute leukaemia), 2 sarcomas, 3 central nervous system cancers and 3 head and neck cancers.

Related Companies/Industries:

1. Bio-Rad Laboratories

2. Metabolon

3. Agilent Technologies Inc.

4. Bruker Corporation

5. Human Metabolome Technologies Inc.

6. LECO Corporation

7. Shimadzu Corporation

8. Thermo Fisher Scientific Inc.

9. Waters Corporation

10. Genomatica

11. Bayer CropScience

12. Cargill

13. Nonlinear Dynamics

14. Nightingale Health

15. LifeOmic

Importance and Scope:

Cancer 2020 deals with Breast cancer knowledge and characteristics, Screening, Detecting and Diagnosing Breast Cancer, Breast cancer therapy, prevention and medicine, Surgery Choices for Breast Cancer, Personilized Medicine, Clinical trials of Breast Cancer, Male Breast Cancer and Breast cancer Nursing. Breast cancer is the main type of cancer from which most of the women are suffering worldwide. Awareness about the breast cancer risks, symptoms and treatment is very important. Introduction of new techniques in the field of medicine as well as diagnosis is going on worldwide. Euro Breast Cancer 2020 provide a platform for sharing of information about the breast cancer treatment techniques and newly developed techniques for the same as well as provide platform about the recent researches on breast cancer. This event includes prompt keynote presentations, oral talks, poster presentations and exhibitions.

• Global Summit on Clinical Trials of Cancer Research

  June 15-16, 2021

  Barcelona, Spain